Elevated mia serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanoma

  • Authors:
    • Markus Guba
    • Markus Steinbauer
    • Verena Ruhland
    • Alexander Schutz
    • Edward K. Geissler
    • Matthias Anthuber
    • Thomas Vogt
    • Anja Bosserhoff
    • Karl-Walter Jauch
  • View Affiliations

  • Published online on: September 1, 2002     https://doi.org/10.3892/or.9.5.981
  • Pages: 981-984
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The secreted MIA protein is upregulated in melanocytic tumors and expression parallels the progressive malignancy of melanoma cells. Recent reports suggest MIA as a diagnostic tumor marker that may also serve as an indicator of tumor progression. In this study we evaluated the association between pre- and post-treatment serum levels of MIA and survival in 70 patients with advanced melanoma. Elevated (≥8.8 ng/ml) pre-treatment levels of MIA predicted a poor prognosis in these patients. Overall median survival in stages III and IV was 13 months in MIA positive patients, compared to 28 months in patients with negative pre-treatment MIA levels. The staging-related analysis showed a median survival of 14 months in MIA positive patients, versus 28 months in MIA negative patients in stage III, and 12, versus 19, months in stage IV melanoma, respectively. In addition, there was a trend towards a poorer survival in patients where MIA serum levels remained high after surgery. Therefore, determination of pre- and post-treatment serum MIA levels could be useful for the management and prognosis of metastatic melanoma patients.

Related Articles

Journal Cover

September-October 2002
Volume 9 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Guba M, Steinbauer M, Ruhland V, Schutz A, Geissler EK, Anthuber M, Vogt T, Bosserhoff A and Jauch K: Elevated mia serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanoma. Oncol Rep 9: 981-984, 2002
APA
Guba, M., Steinbauer, M., Ruhland, V., Schutz, A., Geissler, E.K., Anthuber, M. ... Jauch, K. (2002). Elevated mia serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanoma. Oncology Reports, 9, 981-984. https://doi.org/10.3892/or.9.5.981
MLA
Guba, M., Steinbauer, M., Ruhland, V., Schutz, A., Geissler, E. K., Anthuber, M., Vogt, T., Bosserhoff, A., Jauch, K."Elevated mia serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanoma". Oncology Reports 9.5 (2002): 981-984.
Chicago
Guba, M., Steinbauer, M., Ruhland, V., Schutz, A., Geissler, E. K., Anthuber, M., Vogt, T., Bosserhoff, A., Jauch, K."Elevated mia serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanoma". Oncology Reports 9, no. 5 (2002): 981-984. https://doi.org/10.3892/or.9.5.981